Pay in 4 interest-free payments of $6.23 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
If you dont have diabetes and your doctor prescribes Ozempic off-label for weight loss, most insurance plans deny coverage
The only published human pharmacokinetic study of cagrilintide is Enebo and colleagues phase 1b trial ( Lancet , 2021
It is currently in Phase 3 clinical trials conducted by Eli Lilly
Wegovy prescribed for weight management is covered by a growing number of commercial insurance plans and increasingly by Medi-Cal, though prior authorization is typically required
US$ 20.26
US$ 21.12
US$ 26.20
